capecitabine

You have access
Comparison of Sinusoidal Obstruction Syndrome in Gastric Cancer Patients Receiving S-1/oxaliplatin Versus Capecitabine/oxaliplatin
EO JIN KIM, MOONHO KIM, SEYOUNG SEO, MI-JUNG KIM, MIN JU KIM and SOOK RYUN PARK

Anticancer Research January 2021, 41 (1) 391-402; DOI: https://doi.org/10.21873/anticanres.14788
You have access
Current Status of Therapeutic Drug Monitoring of 5-Fluorouracil Prodrugs
YASUHIRO HASHIMOTO, YOICHIRO YOSHIDA, TEPPEI YAMADA, NAOYA AISU, GUMPEI YOSHIMATSU, FUMIHIRO YOSHIMURA and SUGURU HASEGAWA

Anticancer Research August 2020, 40 (8) 4655-4661; DOI: https://doi.org/10.21873/anticanres.14464
You have access
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
JEAN-DAVID FUMET, JULIE VINCENT, LEILA BENGRINE, AUDREY HENNEQUIN, LAURA GRANCONATO, REMI PALMIER and FRANÇOIS GHIRINGHELLI

Anticancer Research July 2020, 40 (7) 4011-4015; DOI: https://doi.org/10.21873/anticanres.14395
You have access
Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling
JAE JUN SIM, MIN HEE PARK, JEONG-HEUM BAEK, HAEJUN LEE, KEUN-YEONG JEONG and HWAN MOOK KIM

Anticancer Research August 2018, 38 (8) 4667-4676; DOI: https://doi.org/10.21873/anticanres.12772
You have access
Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study
KIYOSHI MAEDA, MASATSUNE SHIBUTANI, HIROSHI OTANI, TATSUNARI FUKUOKA, YASUHITO ISEKI, SHINJI MATSUTANI, HISASHI NAGAHARA, TORU INOUE, AKIKO TACHIMORI, TAKAFUMI NISHII, YOSHITAKA MIKI, MASAKO HOSONO and MASAICHI OHIRA

Anticancer Research July 2018, 38 (7) 4193-4197; DOI: https://doi.org/10.21873/anticanres.12713
You have access
A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage II/III Colon Cancer –ACTOR Study–
MITSUKUNI SUENAGA, TAKASHI AKIYOSHI, EIJI SHINOZAKI, YOSHIYA FUJIMOTO, SATOSHI MATSUSAKA, TSUYOSHI KONISHI, SATOSHI NAGAYAMA, YOSUKE FUKUNAGA, KAZUYOSHI KAWAKAMI, TAKASHI YOKOKAWA, TAKAHITO SUGISAKI, MASASHI UENO and TOSHIHARU YAMAGUCHI

Anticancer Research March 2018, 38 (3) 1741-1747;
You have access
Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer
HIRONAGA SATAKE, MASATO KONDO, MOTOKO MIZUMOTO, TAKESHI KOTAKE, YOSHIHIRO OKITA, TAKATSUGU OGATA, YUKIMASA HATACHI, HISATERU YASUI, AKIRA MIKI, YUKIHIRO IMAI, CHIHIRO ICHIKAWA, KENTA MUROTANI, MASAHITO KOTAKA, TAKESHI KATO, SATOSHI KAIHARA and AKIHITO TSUJI

Anticancer Research July 2017, 37 (7) 3703-3710;
You have access
Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence – A Phase II Study
WOLFGANG EISTERER, GUDRUN PIRINGER, ALEXANDER DE VRIES, DIETMAR ÖFNER, RICHARD GREIL, JÖRG TSCHMELITSCH, HELLMUT SAMONIGG, LIDIJA SÖLKNER, MICHAEL GNANT, JOSEF THALER and On behalf of the Austrian Breast and Colorectal Cancer Study Group

Anticancer Research May 2017, 37 (5) 2683-2691;
You have access
A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer
CHUN-RU CHIEN, WILLIAM TZU-LIANG CHEN, HWEI-MIN WANG, TAO-WEI KE, HUA-CHE CHIANG, SHENG-CHI CHANG, YU-CHUN HUANG, CHE-HUNG LIN, CHUN-LIN HUANG, YING-CHUN LIN, TSUNG-WEI CHEN, CHIA-CHIN LI and K.S. CLIFFORD CHAO

Anticancer Research November 2016, 36 (11) 6155-6160;
You have access
Assessment of Pharmacokinetic Interaction Between Capecitabine and Cetuximab in Metastatic Colorectal Cancer Patients
VERONIKA RACHAR, MARTIN CZEJKA, MARIE KITZMUELLER, PHILIPP BUCHNER, MARIA LICHTNECKERT, RICHARD GREIL, HERBERT GEILER and CHRISTIAN DITTRICH

Anticancer Research September 2016, 36 (9) 4715-4723;

Main menu

User menu

Search

capecitabine

Pages